Gilead Sciences Inc (GILD) support and resistance · P/E 18, rev $29.44B
Gilead Sciences Inc (GILD) is a drug manufacturers - general company listed on US.
This page maps Gilead Sciences Inc (GILD) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported GILD revenue for 2025-12-31 was $29.44B. Net income was $8.51B. Revenue was up 2.4% from 2024-12-31 to 2025-12-31. GILD currently screens at market cap $160.15B and trailing P/E 17.5.
GILD currently screens at market cap $160.15B and trailing P/E 17.5. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new GILD 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the GILD quote page for the session range and the stock page for the full model.
Not investment advice.